Context Therapeutics Executives Increase Holdings
| Reporter Name | Relationship | Type | Amount | SEC Filing |
|---|---|---|---|---|
| Minai-Azary Jennifer Lynn | Chief Financial Officer | Purchase | $25,486 | Form 4 |
| Levit Alex C. | Chief Legal Officer, Corp. Sec | Purchase | $11,520 | Form 4 |
Jennifer Lynn Minai-Azary, Chief Financial Officer of Context Therapeutics, has significantly increased her stake in the company by purchasing 40,010 shares of Common Stock on June 6, 2025, at a weighted average price of $0.637 per share, resulting in a total investment of $25,486. This transaction has doubled her direct ownership to 80,010 shares. The shares were acquired at prices ranging from $0.57 to $0.68.
Alex C. Levit, Chief Legal Officer and Corporate Secretary of Context Therapeutics, also expanded his holdings by acquiring 20,000 shares at a weighted average price of $0.576 per share on the same day, totaling $11,520. Post-transaction, Levit's direct ownership has increased to 29,000 shares, with an additional 52,983 shares held indirectly through his spouse.